Kolinpharma SpA
MIL:KIP
Kolinpharma SpA
MIL:KIP
Price:
9.9
EUR
Market Closed
Market Cap:
€16.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kolinpharma SpA
MIL:KIP
|
IT |
|
B
|
Biogen Inc
BMV:BIIB
|
US |
|
Saudi British Bank SJSC
SAU:1060
|
SA |
|
K
|
Koszalinskie Przedsiebiorstwo Przemyslu Drzewnego SA
WSE:KPD
|
PL |
|
R
|
Raisio Oyj
OMXH:RAIVV
|
FI |
|
T
|
Taghill Holdings Bhd
KLSE:TAGHILL
|
MY |
|
Quantum Health Group Ltd
ASX:QTM
|
AU |
|
Solaris Resources Inc
TSX:SLS
|
CA |
|
Super Micro Computer Inc
NASDAQ:SMCI
|
US |
|
GECI International SA
PAR:ALGEC
|
FR |
|
G
|
Guobo Electronics Co Ltd
SSE:688375
|
CN |
|
Surya Esa Perkasa Tbk PT
IDX:ESSA
|
ID |
|
V
|
VCREDIT Holdings Ltd
HKEX:2003
|
CN |
Balance Sheet
Balance Sheet Decomposition
Kolinpharma SpA
Kolinpharma SpA
Balance Sheet Decomposition is not available for
Kolinpharma SpA
Kolinpharma SpA
Balance Sheet
Kolinpharma SpA
Kolinpharma SpA
Currency: EUR
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
1
|
2
|
4
|
6
|
10
|
|
| Cash |
0
|
0
|
0
|
1
|
2
|
4
|
6
|
10
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
2
|
2
|
4
|
3
|
6
|
5
|
5
|
|
| Accounts Receivables |
0
|
0
|
2
|
3
|
3
|
6
|
4
|
5
|
|
| Other Receivables |
1
|
2
|
0
|
1
|
0
|
0
|
1
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
2
|
3
|
5
|
6
|
11
|
12
|
16
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
2
|
2
|
3
|
4
|
4
|
6
|
6
|
6
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
4
+28%
|
6
+38%
|
9
+47%
|
10
+16%
|
17
+61%
|
19
+11%
|
22
+19%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
3
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Current Liabilities |
3
|
3
|
4
|
3
|
4
|
4
|
5
|
10
|
|
| Long-Term Debt |
0
|
1
|
1
|
1
|
1
|
5
|
5
|
4
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
4
+42%
|
5
+14%
|
4
-11%
|
5
+19%
|
9
+78%
|
10
+13%
|
14
+34%
|
|
| Equity | |||||||||
| Common Stock |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
1
|
1
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
4
|
4
|
4
|
4
|
4
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
-67%
|
1
+731%
|
5
+273%
|
5
+13%
|
8
+45%
|
8
+8%
|
8
+2%
|
|
| Total Liabilities & Equity |
3
N/A
|
4
+28%
|
6
+38%
|
9
+47%
|
10
+16%
|
17
+61%
|
19
+11%
|
22
+19%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
